SCHEMBL12315472

SCHEMBL12315472

CC1(C)C=Cc2cc(C(=O)C([18F])c3ccc(C(C)(C)C)cc3)ccc2O1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 12/20 0.44
▸ COXFA4 O00483 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ EPAS1 Q99814 10/20 0.37
▸ PTPN1 P18031 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ HSD17B10 Q99714 2/20 0.34
▸ TSHR P16473 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CA7 P43166 1/20 0.34
▸ RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12315608 1.00 HIF1A (0.44) HIF1ACOXFA4ALDH1A1HPGDCYP3A4
SCHEMBL12315601 0.80 COXFA4 (0.41) HIF1ACOXFA4ALDH1A1HPGDCYP3A4
SCHEMBL12315466 0.79 COXFA4 (0.46) HIF1ACOXFA4ALDH1A1HPGDCYP3A4
SCHEMBL14666131 0.78 HIF1A (0.54) HIF1ACOXFA4EPAS1
SCHEMBL12315553 0.78 COXFA4 (0.62) HIF1ACOXFA4EPAS1
SCHEMBL12315607 0.75 HIF1A (0.56) HIF1ACOXFA4EPAS1
SCHEMBL9581577 0.75 ALDH1A1 (0.43) HIF1ACOXFA4ALDH1A1HPGDCYP3A4
SCHEMBL12315469 0.75 COXFA4 (0.66) HIF1ACOXFA4ALDH1A1TDP1EPAS1
SCHEMBL7766618 0.73 COXFA4 (0.49) HIF1ACOXFA4ALDH1A1HPGDCYP3A4
SCHEMBL14666254 0.73 HIF1A (0.48) HIF1ACOXFA4EPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130028837-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING LANTHEUS MEDICAL IMAGING, INC. (US) 2013-01-31 — — US disclosed
US-8263042-B2 Contrast agents for myocardial perfusion imaging LANTHEUS MEDICAL IMAGING, INC. (US) 2012-09-11 — — US disclosed
US-20090104118-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING CITIZENS BANK, N.A. 2009-04-23 — — US disclosed
US-7485283-B2 Contrast agents for myocardial perfusion imaging LANTHEUS MEDICAL IMAGING (US) 2009-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104118-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING TNNI3, TNNT2, FABP3 HIF1A 887/4885COXFA4 2119/4885ALDH1A1 2228/4885
US-20130028837-A1 CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING TNNI3, TNNT2, FABP3 HIF1A 887/4885COXFA4 2119/4885ALDH1A1 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback